Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
The extensive SURPASS clinical trials, encompassing eight completed studies, have evaluated tirzepatide as both monotherapy and in combination with other treatments (4)
Regular follow-up appointments allow for assessment of both diabetes control and gastrointestinal symptoms, ensuring optimal management of both conditions
If you have signs of an allergic reaction, you want to get emergency medical help right away
Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a 39-amino acid dual agonist targeting both GLP-1 and GIP receptors, also incorporating a fatty acid modification for half-life extension, and is the most commercially significant synthetic peptide ever produced at scale
Your Ivm provider will explain your options and help you choose the right solution based on your needs
